Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin add-on to Escitalopram in MDD and Obesity
NCT04301271Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Aug 2020
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simvastatin in major depressive disorder (MDD), sponsored by Charité – Universitätsmedizin Berlin. Started Aug 2020; status: completed.
02
Drugs
simvastatin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04301271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04301271.